Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Controlled-Release (HC-CR) in Subjects With Hepatic Impairment

NCT02242734 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: 20 mg HC-ER
DRUG: 20 mg HC-ER
DRUG: 20 mg HC-ER

Sponsor

Zogenix, Inc.